in Re Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc.

CourtCourt of Appeals of Texas
DecidedMarch 8, 2018
Docket14-18-00036-CV
StatusPublished

This text of in Re Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. (in Re Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
in Re Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc., (Tex. Ct. App. 2018).

Opinion

Petition for Writ of Mandamus Conditionally Granted and Memorandum Opinion filed March 8, 2018.

In The

Fourteenth Court of Appeals

NO. 14-18-00036-CV

IN RE NAVIDEA BIOPHARMACEUTICALS, INC. AND MACROPHAGE THERAPEUTICS, INC., Relators

ORIGINAL PROCEEDING WRIT OF MANDAMUS 151st District Court Harris County, Texas Trial Court Cause No. 2016-22242

MEMORANDUM OPINION

On January 19, 2018, relators Navidea Biopharmaceuticals, Inc. and Macrophage Therapeutics, Inc. (collectively, “Navidea”) filed a petition for writ of mandamus in this court. See Tex. Gov’t Code Ann. § 22.221 (West Supp. 2017); see also Tex. R. App. P. 52. In the petition, Navidea asks this court to compel the Honorable Mike Engelhart, presiding judge of the 151st District Court of Harris County, to set a supersedeas bond amount. Real parties in interest are Capital Royalty Partners II, L.P.; Capital Royalty Partners II – Parallel Fund “A”, L.P.; Parallel Investment Opportunities Partners II, L.P.; Capital Royalty Partners II (Cayman) L.P.; and Capital Royalty Partners II – Parallel Fund “B” (Cayman) L.P. (collectively, “CRG”). We conditionally grant the petition.

BACKGROUND

CRG loaned $50 million to Navidea in 2015. CRG claimed that Navidea defaulted on the loan. According to the verified facts contained in Navidea’s petition, CRG then “swept” $4.1 million from Navidea’s bank accounts (the “Swept Funds”), and filed suit against Navidea. Thereafter, the parties entered into a global settlement agreement (“Settlement Agreement”). Pursuant to the Settlement Agreement, Navidea immediately paid CRG $59 million. The Settlement Agreement provided that the trial court was to determine a final obligation amount, which was to be no less than $47 million and no more than $66 million. Further, under the Settlement Agreement, the parties agreed that (1) Navidea retained the right to assert entitlement to all offsets and credits, including “without limitation, the credit due for the U.S. Bank funds previously taken by Lenders”; and (2) “the Texas Court’s decision shall be final and non-appealable and not subject to reconsideration, and shall be binding on all of the Parties to this Agreement.”

On December 27, 2017, the trial court signed a final judgment, ordering that CRG recover $66 million from Navidea. The order further stated, “To be clear, though, this judgment requires Defendants ‘Navidea’ to pay an additional Seven Million Dollars ($7,000,000.00) in new money on top of the Fifty Nine Million Dollars that ‘Navidea’ has already paid pursuant to the 2017 settlement agreement entered into prior to the commencement of the trial of this case.” 2 Navidea filed a motion to modify or correct the judgment and stay enforcement of the judgment. On January 3, 2018, the trial court granted a stay and signed the following order:

After reviewing the pleadings on file and any arguments of counsel, the Court hereby stays the execution of its Judgment which would otherwise be immediately collectible and executable through 5 p.m. Houston time on Wednesday, January 10, 2018. The Court will either enter an amended Judgment and Findings and Conclusions by that time, or not. No additional filings will be considered, and no additional hearings will be held. CRG filed a response to Navidea’s motion. The trial court struck CRG’s response, stating:

On its own Motion, the Court hereby STRIKES from the record in this case Plaintiffs’ January 5, 2018 “Response in Opposition to Defendants’ Motion to Correct Judgment, and Plaintiff’s [sic] Motion to Enforce the Global Settlement Agreement” as well as the cover letter and propose [sic] order filed with that Response. The Court’s January 3, 2018 Order plainly stated that no further filings would be accepted. Plaintiffs’ [sic] acknowledge this in their cover letter. Plaintiffs nevertheless ignored the Court’s Order. The Court means what it says in its Orders. Any further filings by either side in this case may result in a show cause order from the Court regarding substantial sanctions.

On January 10, 2018, the trial court signed the following first amended final judgment, which stated in part:

IT IS ORDERED, ADJUDGED, AND DECREED that Plaintiffs recover from Defendants the amount of $7,000,000.00 in damages, which is new money, in addition to the $59,000,000.00 previously paid to Plaintiffs pursuant to the high-low settlement agreement in this case.

3 IT IS FURTHER ORDERED that the Plaintiffs recover from Defendants post-judgment interest at the rate of 5% per annum from the date of this Amended Final Judgment.

The Court Orders, Adjudges, and Decrees that this Amended Final Judgment replaces the Final Judgment signed on December 27, 2017, and this Amended Final Judgment disposes of all claims, all defenses, and all parties. It is further ORDERED that no additional filings or motions or corrections will be accepted by the Court pursuant to the plain language of the Parties’ agreements. Further, the Court will not hold any additional hearings in this case.

The trial court also entered findings of fact and conclusions of law.

On January 16, 2018, Navidea filed an emergency motion to set a supersedeas bond and to modify the judgment. In its emergency motion, Navidea argued that the amended final judgment did not expressly credit $4,112,434.17, which was the amount of the Swept Funds Navidea previously paid above the $59 million settlement amount. Navidea explained that the parties disagreed about the meaning of the phrase in the judgment, “new money, in addition to the $59 million previously paid.” Navidea contended that the $7 million includes the $4,112,434.17 in Swept Funds; CRG believed that the $7 million does not include the Swept Funds. Navidea asserted that, if CRG’s interpretation were correct, CRG would be entitled to collect $70,112,434.17, which is more than the maximum amount of $66 million permitted by the Settlement Agreement. Navidea asked the trial court to modify the judgment “to clearly show which party is clearly right.” Navidea stated that such modification would “let [Navidea] know whether an appeal of the Court’s damages award is warranted.”

4 Under the Settlement Agreement, CRG can collect amounts owed by Navidea by drawing on a letter of credit five days after entry of judgment, and, according to Navidea, CRG had attempted to draw the full $7 million on the letter of credit. Therefore, Navidea asked the trial court to (1) set a supersedeas bond in the amount of $2,887.565.83; or (2) stay enforcement of the judgment until the court set a supersedeas bond amount. Navidea stated that it filed the motion to protect its rights for a potential appeal, and that its motion did not implicate the contractual waiver of appeal of the trial court’s determination of the final obligation amount. Navidea stated it may appeal the judgment “at least to the extent it does not credit [Navidea] with its payment of the Swept Funds and requires total payment in excess of the $66 million ceiling set by the high-low provision of the Settlement Agreement.”

Navidea also filed a supplement to its emergency motion to set a supersedeas bond and to modify the judgment. The following comment was included in the electronic notice that Navidea’s supplement was accepted for filing:

Please be advise [sic]. The Court will NOT consider Defendants’ Emergency Motion to Set Supersedeas Bond and to Modify Judgment and this Supplement as per Judgment and FOF/COL signed 01/10/2018. Thank you for your attention in this matter.

Navidea then filed its petition for writ of mandamus, in which it asserts that the trial court abused its discretion by refusing to set a supersedeas bond amount. Navidea also filed an emergency motion to stay the judgment. We granted the stay and requested CRG to respond to the mandamus petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Prudential Insurance Co. of America
148 S.W.3d 124 (Texas Supreme Court, 2004)
In Re Van Waters & Rogers, Inc.
145 S.W.3d 203 (Texas Supreme Court, 2004)
In Re Cerberus Capital Management, L.P.
164 S.W.3d 379 (Texas Supreme Court, 2005)
Miga v. Jensen
299 S.W.3d 98 (Texas Supreme Court, 2009)
Elizondo v. Williams
643 S.W.2d 765 (Court of Appeals of Texas, 1982)
Vineyard v. Irvin
855 S.W.2d 208 (Court of Appeals of Texas, 1993)
In Re Ford Motor Co.
165 S.W.3d 315 (Texas Supreme Court, 2005)
In Re Crow-Billingsley Air Park, Ltd.
98 S.W.3d 178 (Texas Supreme Court, 2003)
Continental Oil Company v. Lesher
500 S.W.2d 183 (Court of Appeals of Texas, 1973)
Houtchens v. Mercer
29 S.W.2d 1031 (Texas Supreme Court, 1930)
Ex Parte G.O. Kimbrough
146 S.W.2d 371 (Texas Supreme Court, 1941)
in Re National Lloyds Insurance Company
507 S.W.3d 219 (Texas Supreme Court, 2016)
Burgher v. Chrisman
604 S.W.2d 536 (Court of Appeals of Texas, 1980)
In re H.E.B. Grocery Co.
492 S.W.3d 300 (Texas Supreme Court, 2016)
Washington v. Golden State Mutual Life Insurance
396 U.S. 839 (Supreme Court, 1969)

Cite This Page — Counsel Stack

Bluebook (online)
in Re Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-navidea-biopharmaceuticals-inc-and-macrophage-therapeutics-inc-texapp-2018.